RICHMOND, Calif., Jan. 4, 2019 /PRNewswire/
-- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today
that Sandy Macrae, CEO of Sangamo,
will present a corporate overview at the 37th Annual
J.P. Morgan Healthcare Conference on Wednesday, January 9th at 11:30 a.m. PT in San
Francisco. Dr. Macrae's presentation will be followed by a
separate Q&A session starting at 12:00
p.m. PT.
The presentation and Q&A session will be webcast live and
may be accessed via a link on the Sangamo Therapeutics website in
the Investors and Media section under Events and
Presentations. The presentation will be archived on the Sangamo
website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
medicines with the potential to transform patients' lives using the
Company's platform technologies in genome editing, gene therapy,
gene regulation and cell therapy. For more information about
Sangamo, visit www.sangamo.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300772882.html
SOURCE Sangamo Therapeutics, Inc.